News About: Pharm. Industry
Boram to build new cGMP plantBoram Pharm, a local pharmaceutical manufacturer, embarked on a project to create a new GMP plant at Jaechon Biovalley industrial park, Chungbuk Province in a ground-breaking ce...
|
Strategic decision enhances efficiency of new drug developmentThe strategic decisions that you participate in shape the direction and success of your new drug, said Prof. Carl S. Spetzler of the U.S. Stanford University who visited Seoul.
...
|
Having holidays at Saturdays gets tough
Thanks God, it's Friday? But for those at sales department Saturdays seem to have given way to seminar and education even after all pharmaceutical companies adopt the five-day workweek system.
Most companies that h...
PuriMed announces Phase II clinical trial of lotus seed in depression patients
PuriMed, a local biopharmaceutical company, has recently announced the commencement of the Phase II clinical trial in patients with depression using a natural product PM011 (trade name: Lotuzol).
This control, doub...
Hyundai Pharm launches oral nicotine replacement therapyHyundai is poised to conquer the market for oral nicotine replacement therapies with Nicopass through its partnership with Pierre Fabre in France.
The company said on October...
|
Drug makers agonize over price cut of amlodipine generics
About 30 pharmaceutical firms, who are engaged in producing amlodipine maleate preparations, are attentively watching the government's final announcement on October 19, following the decision of the Health Insurance R...
Bayer Healthcare opens web site for prevention of cardiovascular disease
Bayer Healthcare Korea said on October 10 that it has opened its health web site (www.bayer-happy100.co.kr) to prevent ever-increasing cardiovascular disease in elderly people.
Cardiovascular diseases have become ...
Daewoong launches new smokeless tobacco patchDaewoong Pharm is introducing its new smokeless tobacco patch 'Nicoman Patch' with less nicotine content from this month, following other two types nicotine troche and gum last...
|
MSD Korea targets antidiabetic market
Industry watchers expect the domestic antidiabetic market is about to heat up, as MSD Korea's sitagliptin phosphate (Januvia), an oral diabetes medication in a new class of drugs known as DPP-4 inhibitors, will soon j...
Kim Ok-yeon to lead Janssen-Cilaq MalaysiaKim Ok-yeon, vice president of vice president of Johnson and Johnson Asia and Pacific marketing operation, has been named new president of Janssen-Cilaq Malaysia, according to J...
|
